4//SEC Filing
LYNCH DANIEL 4
Accession 0001104659-25-015215
CIK 0001773427other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 4:49 PM ET
Size
4.7 KB
Accession
0001104659-25-015215
Insider Transaction Report
Form 4
LYNCH DANIEL
Director
Transactions
- Sale
Common Stock
2025-02-14$60.00/sh−400$24,000→ 130,544 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on May 3, 2024.
Documents
Issuer
SpringWorks Therapeutics, Inc.
CIK 0001773427
Entity typeother
Related Parties
1- filerCIK 0001177082
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 4:49 PM ET
- Size
- 4.7 KB